Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [517]
News [1431]
Articles [66]
Editorials [2]
Conferences [72]
elearning [5]
The changing landscape of melanoma therapies: indications of better patient...
Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof...
The changing landscape of melanoma therapies: indications of better patient outcome ( Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof Reinhard Dummer )
24 Jun 2011
Role of vemurafenib in melanoma treatment
Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK
Role of vemurafenib in melanoma treatment ( Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK )
24 Jun 2011
Combining oral targeted therapies shows early anti-tumour activity for advanced...
Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
20 Jun 2011
Cancer prevention through education
Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy
Cancer prevention through education ( Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy )
17 Jun 2011
Highlights from 2011 and ASCO’s future
Prof George Sledge - Indiana University, USA
Highlights from 2011 and ASCO’s future ( Prof George Sledge - Indiana University, USA )
17 Jun 2011
Ipilimumab improves survival in metastatic melanoma
Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Ipilimumab improves survival in metastatic melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Jun 2011
New melanoma drug gives 63 percent reduction in risk of death compared to...
Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center
New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine ( Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center )
17 Jun 2011
ASCO 2011 highlights
Prof Gordon McVie – ecancer Managing Editor
ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )
16 Jun 2011
The future of medicine: personalised
Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany
The future of medicine: personalised ( Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany )
2 Jun 2011
Reducing global cancer mortality
Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Reducing global cancer mortality ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
2 Jun 2011
The Cancer Genome Atlas (TCGA)
Dr Paul Spellman - National Cancer Institute, Bethesda, USA
The Cancer Genome Atlas (TCGA) ( Dr Paul Spellman - National Cancer Institute, Bethesda, USA )
21 Apr 2011
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity
Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity ( Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA )
20 Apr 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation